Advertisement
A new gene-editing therapy designed to help treat patients suffering from sickle cell disease has been endorsed by the National Catholic Bioethics Center.
A group of 21 doctors from countries around the world wrote publicly on Thursday that the ongoing push to provide young children with transgender “transition” procedures is unsupported by current evidence and that medical officials should shift their approaches to managing youth gender dysphoria.